PRESCRIBE KLISYRI®
WITH CONFIDENCE
EXPLORE PATIENT SUPPORT AND SAVINGS
At Almirall, our commitment to your PATIENTS WITH AK is at the center of all that we do.
Access and coverage
KLISYRI® HAS BROAD PAYER COVERAGE1
Payer coverage includes 97 million commercial lives1
Percentage of commercial
payer lives that have
KLISYRI® coverage. 1
Percentage of commercial payer lives that have KLISYRI® coverage.1
Many leading plans cover
KLISYRI® for both commercial
and Medicare patients.
Many leading plans cover KLISYRI® for both commercial and Medicare patients.
Co-pay & savings
LOCATE A NETWORK PHARMACY TO ACCESS
CO-PAY CARDS FOR YOUR PATIENTS
Almirall offers cost savings and support for eligible patients*
Help your patients save on their next KLISYRI® prescription with the KLISYRI® co-pay card.
Access the Co-pay Card
Patients may save when you send the prescription to a network pharmacy
Commercially insured patients using the Almirall Advantage Network may pay as low as $25 if covered by insurance, and $95 if not covered by insurance*
Find the nearest in-network pharmacy for optimal coverage
Explore locations
Patients may also save on prescriptions with GoodRx®
For patients without (or who opt not to use) commercial insurance coverage, GoodRx® provides an additional option for improved co-pay assistance and affordability.
Patients may save up to 80% on their KLISYRI® prescription with GoodRx®.†‡
Learn moreCo-pay & savings
LOCATE A NETWORK PHARMACY TO ACCESS CO-PAY CARDS FOR YOUR PATIENTS
Almirall offers cost savings and support for eligible patients*
Help your patients save on their next KLISYRI® prescription with the KLISYRI® co-pay card.
Access the Co-pay CardPatients may save when you send the prescription to a network pharmacy
Commercially insured patients using the Almirall Advantage Network may pay as low as $25 if covered by insurance, and $95 if not covered by insurance*
Find the nearest in-network pharmacy for optimal coverage
Explore locationsPatients may also save on prescriptions with GoodRx®
For patients without (or who opt not to use) commercial insurance coverage, GoodRx® provides an additional option for improved co-pay assistance and affordability.
Patients may save up to 80% on their KLISYRI® prescription with GoodRx®.†‡
Learn moreCompleting the prior authorization (PA) request form
PA support is
available through:
Comprehensive prior authorization
support delivered through CoverMyMeds§
Help your patients get affordable
access to KLISYRI®
- Some insurance companies may require PA and/or step therapy before they cover KLISYRI®
- It is important that the PA request is accurately completed in order to facilitate a determination by the patient’s insurance company
- Please work with your patient’s insurance company to pursue coverage so the patient can benefit from co-pay savings
*Eligible patients with commercial insurance only (non-government) may pay as low as $25. Patients who do not have coverage for KLISYRI® under their commercial insurance may pay $150 at a retail pharmacy or $95 at a pharmacy within the Almirall Advantage network. Terms and conditions apply. Your available savings may vary and are subject to maximum reimbursement limits.
†GoodRx® is not insurance but may be used instead of insurance.
‡Prices may vary at different pharmacies. Check goodrx.com for the most current pricing information near you.
§Use of CoverMyMeds does not guarantee prescription coverage.
IMPORTANT SAFETY INFORMATION
INDICATION
KLISYRI is a microtubule inhibitor indicated for the topical field treatment of actinic keratosis on the face or scalp.
IMPORTANT SAFETY INFORMATION
WARNINGS AND PRECAUTIONS
Ophthalmic Adverse Reactions
KLISYRI may cause eye irritation. Avoid transfer of the drug into the eyes and to the periocular area during and after application. Wash hands immediately after application. If accidental exposure occurs, instruct patient to flush eyes with water and seek medical care as soon as possible.
Local Skin Reactions
Local skin reactions, including severe reactions (erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, and erosion/ulceration) in the treated area can occur after topical application of KLISYRI. Occlusion after topical application of KLISYRI is more likely to result in irritation. Avoid use until skin is healed from any previous drug, procedure, or surgical treatment.
ADVERSE REACTIONS
The most common adverse reactions (incidence ≥2%) were local skin reactions, application site pruritus, and application site pain.
Please see full Prescribing Information.
To report an adverse event or product complaint, call or email Medical Affairs and Customer Relations • Phone: 1-866-665-2782• Fax: 510-595-8183 •
Email: almirallmc@eversana.com
Reference: 1. Managed Markets Insights & Technology, LLC. June 2024.